Rifabutin is active in murine models of toxoplasmosis.
Rifabutin, a semisynthetic derivative of rifamycin S, was examined alone and in combination with other drugs for activity in treatment of systemic toxoplasmosis and toxoplasmic encephalitis in murine models. One hundred percent of the mice infected with a lethal inoculum of tachyzoites or cysts of T...
Na minha lista:
| Publicado no: | Antimicrob Agents Chemother |
|---|---|
| Principais autores: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
American Society for Microbiology (ASM)
1994
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC284499/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8203856/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/aac.38.3.570 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|